Pharmacokinetics of navelbine after oral administration in cancer patients
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 29 (1) , 66-70
- https://doi.org/10.1007/bf00686338
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Pharmacokinetics of a new anticancer drug, navelbine, in patientsCancer Chemotherapy and Pharmacology, 1989
- Steady-state dosage regimen calculations in linear pharmacokineticsInternational Journal of Bio-Medical Computing, 1986
- Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and ratsCancer Chemotherapy and Pharmacology, 1986
- Clinical pharmacokinetics of vindesine: Repeated treatments by intravenous bolus injectionsEuropean Journal of Cancer and Clinical Oncology, 1984
- Experimental antitumor activity of 5′-nor-anhydrovinblastine navelbineCancer Letters, 1984
- The pharmacokinetics of vincristine in man:Cancer Chemotherapy and Pharmacology, 1982
- The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancerMedical and Pediatric Oncology, 1982
- Experimental in vivo cross-resistance of vinca alkaloid drugsCancer Chemotherapy and Pharmacology, 1981
- A new class of antitumor compounds: 5'-nor and 5',6'-seco derivatives of vinblastine-type alkaloidsThe Journal of Organic Chemistry, 1979
- 5'-Nor anhydrovinblastineTetrahedron, 1979